Data supplements
Supplemental Data
Files in this Data Supplement:
Jump to section
Related Articles
Cited By...
- A head-to-head comparison of multiple amyloid PET radiotracers for Down syndrome clinical trials
- Evaluation of plasma p-tau217 for detecting amyloid pathology in a diverse and heterogeneous community-based cohort
- Traumatic brain injury and Alzheimers Disease biomarkers: A systematic review of findings from amyloid and tau positron emission tomography (PET)
- The RSNA QIBA Profile for Amyloid PET as an Imaging Biomarker for Cerebral Amyloid Quantification
- Plasma p-tau181/A{beta}1-42 ratio predicts A{beta}-PET status and correlates with CSF-p-tau181/A{beta}1-42 and future cognitive decline
- Plasma p217+tau vs NAV4694 amyloid and MK6240 tau PET across the Alzheimer continuum
- Determining Amyloid-{beta} Positivity Using 18F-AZD4694 PET Imaging
- Prediction of the Clinical SUV Ratio in Amyloid PET Imaging Using a Biomathematic Modeling Approach Toward the Efficient Development of a Radioligand
- Standardized Expression of 18F-NAV4694 and 11C-PiB {beta}-Amyloid PET Results with the Centiloid Scale
- Visualization and Quantification of 3-Dimensional Stereotactic Surface Projections for 18F-Flutemetamol PET Using Variable Depth
- 18F-THK5351: A Novel PET Radiotracer for Imaging Neurofibrillary Pathology in Alzheimer Disease
- Performance of 11C-Pittsburgh Compound B PET Binding Potential Images in the Detection of Amyloid Deposits on Equivocal Static Images
- Automated Quantification of 18F-Flutemetamol PET Activity for Categorizing Scans as Negative or Positive for Brain Amyloid: Concordance with Visual Image Reads
- Molecular Imaging of Alzheimer Disease Pathology
- Practical utility of amyloid and FDG-PET in an academic dementia center